HealthTech Bio Actives (HTBA), the leading innovator of polyphenols and vitamin B12 for health and nutrition, is set to return to CPHI Worldwide with an ambitious goal to forge strategic partnerships for the development of innovative flavonoids. Focused on delivering the next generation of patient-centric health solutions, the company will spotlight its science-based expertise in the manufacture and commercialization of natural flavonoids and vitamin B12 active forms. This comes following the announcement of HTBA’s partnership with Abolis Biotechnologies for the advancement of sustainable, high-value polyphenols earlier this year, highlighting its commitment to pioneering cutting-edge nature-led active pharmaceutical ingredients (APIs).
CPHI Milan presents the perfect platform for us to cultivate new partnerships while continuing to deliver world-class, science-backed ingredients that harness the power of nature to promote health and wellbeing,” comments Álvaro Nocete, Pharma Division Director at HTBA. “With over 40 years’ experience as a leading European API manufacturer, we’re excited to explore opportunities to expand beyond citrus flavonoids by tapping into new vegetal sources. In addition, we want to broaden the scientific foundation of our ingredients, continue to develop innovative processing technologies that promote sustainable and environmentally-friendly manufacturing, and spearhead advancements in regulatory standards. Collaboration will be key to driving these breakthroughs forward.”
To start a conversation or find out more about HTBA’s established premium-quality portfolio, including diosmin, hesperidin and methylcobalamin, visit booth #2B74.
